72235-58-6 Usage
Uses
Used in Pharmaceutical Industry:
4-Chloro-3-fluorobenzylamine is used as a key building block for the synthesis of various pharmaceuticals. Its unique structure with chlorine and fluorine substitutions allows for the development of new drugs with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4-Chloro-3-fluorobenzylamine is utilized as an essential component in the creation of pesticides and other agrochemical products. Its chemical properties make it suitable for enhancing the effectiveness of these products in agricultural applications.
Used in Organic Compound Production:
4-Chloro-3-fluorobenzylamine serves as a valuable intermediate in the production of organic compounds. Its presence in the synthesis process can lead to the development of novel organic materials with diverse applications across various industries.
Used in Research and Development:
4-Chloro-3-fluorobenzylamine is also used in research and development initiatives, where it aids in the exploration and creation of new chemical products. Its unique characteristics make it a promising candidate for scientific studies aimed at discovering innovative applications and improving existing ones.
Check Digit Verification of cas no
The CAS Registry Mumber 72235-58-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,2,3 and 5 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 72235-58:
(7*7)+(6*2)+(5*2)+(4*3)+(3*5)+(2*5)+(1*8)=116
116 % 10 = 6
So 72235-58-6 is a valid CAS Registry Number.
InChI:InChI=1/C7H7ClFN/c8-6-2-1-5(4-10)3-7(6)9/h1-3H,4,10H2
72235-58-6Relevant academic research and scientific papers
THERAPEUTIC MACROLIDE COMPOUNDS AND THEIR USE
-
Page/Page column 90, 91, (2010/06/17)
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain macrolide compounds (for convenience, collectively referred to herein as "MC compounds"), which, inter alia, are useful in treatment of cancer. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to treat proliferative conditions such as cancer, and in the treatment of diseases and conditions that are mediated by the regulation (e.g. inhibition) of cell proliferation, optionally in combination with another agent.